EU Commission Approves First And Only Enzyme Replacement Therapy For Hunter Syndrome

... The European Commission has granted marketing authorisation for the use of idursulfase (Elaprase(R)), for the long-term treatment of patients with Hunter syndrome.1 Idursulfase, marketed by Shire Human Genetics Therapies, is the first and only enzyme replacement treatment for people suffering from Hunter syndrome (Mucopolysaccharidosis II) since this condition was identified 100 years ago. [click link for full article] ...